OnKure Therapeutics

Public

Boulder, ColoradoBiotechhttps://www.onkuretherapeutics.com

OnKure Therapeutics is now publicly traded

The data on this page reflects OnKure Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Oct 4, 2024

Est. Valuation at Exit

$305.16M

Total Funding Raised

$181M

Company Overview

OnKure Therapeutics operates in Biotech and is based in Boulder, Colorado. It has raised $181M.

OnKure Therapeutics is a biopharmaceutical company dedicated to discovering and developing advanced precision medicines that target validated cancer drivers, addressing unmet needs in current therapies.

Sector

Biotech

AI Layer

Non-AI

OnKure Therapeutics Comparables

Compare OnKure Therapeutics with similar companies based on industry and business-model similarity.

OnKure Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Kirilys Therapeutics	61%	Demo
Eli Lilly and Company	54%	Demo
Vaderis Therapeutics	40%	Demo

Book a demo to see all comparables

For institutional investors. Book with your work email.

OnKure Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Oct 4, 2024	Demo	Demo	Demo	Demo
Series C	Mar 31, 2023	Demo	Demo	Demo	Demo
Series B	Mar 3, 2021	Demo	Demo	Demo	Demo
Series A	May 2, 2018	Demo	Demo	Demo	Demo

Book a demo to see all funding rounds

For institutional investors. Book with your work email.

OnKure Therapeutics Investors

Notable investors and investment history

OnKure Therapeutics investors
Investor	Rounds
Perceptive Advisors	Series B, Private Placement, Series C
Deep Track Capital	Private Placement, Series C
Vestal Point Capital	Private Placement
Delian Capital	Series A
Acorn Bioventures	Private Placement, Series C, Series B
Citadel	Private Placement, Series C, Series B
Samsara BioCapital	Series B, Private Placement, Series C